Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty PotentialAccesswire • about 1 month ago
BOSTON, MA / ACCESSWIRE / March 27, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) provided a corporate update today announcing a strategy to maximize its ability to capture the potential...
Share to Feed
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS Free Report) in a report published on Wednesday. The firm issued a hold rating on the biotechnology...
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS Free Report) in a report published on Tuesday morning. The firm issued a hold rating on the biotechnology...
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a hold rating on...
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS Free Report) in a research note issued to investors on Wednesday. The firm issued a hold rating on the...
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS Free Report) in a research note issued to investors on Wednesday. The firm issued a hold rating on the...